Best, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has enhanced its strength in image-guided therapy innovation with the establishment of a new in-house simulation facility for early and continuous product design validation and end-user testing. The new facility is located at Philips’ existing R&D and manufacturing facility in Best, the Netherlands.

“We have combined our expertise and activities in the field of product design validation and usability testing, and expanded the team, enabling us to validate and test throughout the product creation process from early development to final product,” said Bert van Meurs, General Manager, Philips Image Guided Therapy. “Our goal is to further enhance the user experience and enable the effective and efficient use of our technology - for example during critical procedures such as the minimally-invasive treatment of a heart attack or stroke.”